[Case Study] Keio University School of Medicine Cardiovascular Regenerative Medicine Center
Case study of introducing the 'AC800', a large-scale CO2 incubator equipped with an automatic control robotic hand!
We have introduced the automated controlled robotic hand-equipped large-scale CO2 incubator 'AC800' at the Keio University School of Medicine's Center for Cardiac Regenerative Medicine. The robotic hand automatically transports cell culture containers from the sterile operation unit to the culture stage. Used items such as cell culture containers are expelled from a dedicated waste disposal box, enabling all necessary tasks to be performed within the incubator. Optional features include a waste disposal box, dedicated CO2 chamber, microscope unit, and forced CO2 ventilation system. [Overview] - Introduced a large-scale CO2 incubator equipped with an automated controlled robotic hand - Automatically transports cell culture containers from the sterile operation unit to the culture stage - Enables all necessary tasks within the incubator - The main unit has corrosion resistance due to hydrogen peroxide vapor decontamination *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Options】 ■Waste Disposal Box ■Dedicated CO2 Chamber ■Microscope Unit ■CO2 Forced Ventilation Mechanism *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Implementation Results】 ■Keio University School of Medicine, Center for Cardiac Regenerative Medicine *For more details, please refer to the PDF document or feel free to contact us.
catalog(1)
Download All CatalogsCompany information
BioMedica Solutions Co., Ltd. is a company formed through collaboration between Panasonic Healthcare Co., Ltd. (formerly Sanyo Electric Co., Ltd. BioMedica Division), a top manufacturer of cell culture processing facilities and equipment, and Terra Co., Ltd., which possesses cell culture technology, know-how, and the largest track record of human cell culture in Japan. We aim to provide the latest cell culture technology and management know-how, contributing to the realization of regenerative medicine and cell therapy, and striving for a society where many people can safely receive cell therapy.